Page last updated: 2024-08-23

epirubicin and Chemotherapy-Induced Febrile Neutropenia

epirubicin has been researched along with Chemotherapy-Induced Febrile Neutropenia in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	6 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiarotto, JA; Dranitsaris, G	1
Ali, Z; Malik, Z; Misra, V; Mullard, AP; O'Reilly, SM; Sumra, P	1
Arnould, L; Bonnetain, F; Borg, C; Cleau, D; El Gani, M; Fein, F; Fratté, S; Ghiringhelli, F; Jacquin, M; Jary, M; Kim, S; Lamfichekh, N; Lassabe, C; Mathieu, P; Nerich, V; Nguyen, T; Paget-Bailly, S; Valmary-Degano, S	1
Assi, H; Boyle, L; Murray, J; Rayson, D	1
Amadori, D; Bongiovanni, A; De Vita, A; Di Iorio, V; Foca, F; Ibrahim, T; Liverani, C; Mercatali, L; Miserocchi, G; Monti, M; Recine, F; Riva, N	1
Capelan, M; Lote, H; Mohammed, K; Papadimitraki, E; Redana, S; Ring, A; Sharp, A	1

Trials

1 trial(s) available for epirubicin and Chemotherapy-Induced Febrile Neutropenia

Article	Year
Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer. Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Cohort Studies; Drug Monitoring; Epirubicin; Esophageal Neoplasms; Esophagus; Feasibility Studies; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pilot Projects; Severity of Illness Index; Stomach; Stomach Neoplasms; Survival Analysis	2014

Article

Year

Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.

Cancer chemotherapy and pharmacology, 2014, Volume: 74, Issue:1

Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Cisplatin; Cohort Studies; Drug Monitoring; Epirubicin; Esophageal Neoplasms; Esophagus; Feasibility Studies; Female; Follow-Up Studies; Humans; Leukopenia; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pilot Projects; Severity of Illness Index; Stomach; Stomach Neoplasms; Survival Analysis

2014

Other Studies

5 other study(ies) available for epirubicin and Chemotherapy-Induced Febrile Neutropenia

Article	Year
Full-dose chemotherapy in early stage breast cancer regardless of absolute neutrophil count and without G-CSF does not increase chemotherapy-induced febrile neutropenia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoplasm Staging; Neutrophils; Retrospective Studies; Risk Factors; Taxoids	2013
Reducing febrile neutropenia rates in early breast cancer. Experience of two UK cancer centres. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:8 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy-Induced Febrile Neutropenia; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Medical Audit; Middle Aged; Retrospective Studies; Risk Factors; Taxoids; Young Adult	2014
Incidence of febrile neutropenia in early stage breast cancer patients receiving adjuvant FEC-D treatment. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:12 Topics: Adjuvants, Pharmaceutic; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Canada; Chemoprevention; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Incidence; Middle Aged; Neoplasm Staging; Retrospective Studies; Risk Factors; Taxoids	2014
Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017, Volume: 25, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Agents; Humans; Ifosfamide; Lenograstim; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Sarcoma	2017
Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population. Breast (Edinburgh, Scotland), 2016, Volume: 30 Topics: Acute Coronary Syndrome; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy-Induced Febrile Neutropenia; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Female; Fluorouracil; Humans; Incidence; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Pulmonary Embolism; Retrospective Studies; Risk Factors; Sentinel Lymph Node Biopsy; Stroke; Taxoids; Thromboembolism; Venous Thrombosis	2016